Director, President & CEO · DiaMedica Therapeutics Inc. · Voting Common Shares, no par value per share
Side
A
Value
—
Shares
60.2K
Price
—
Executed
Aug 10, 2026
Disclosed
Aug 12, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 10 executedAug 12, 2026 disclosed
DMAC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 87.8% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Pauls Dietrich John filed this Form 4 reporting a grant or award of DMAC on Aug 10, 2026. It became public on Aug 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President & CEO
Pauls Dietrich Johncik:0001760123
Issuer
DiaMedica Therapeutics Inc.cik:0001401040
Revision history · 0
No field has changed since this record was first ingested.
